NCT04845152已完成不适用
Prevalence of Migraine Disease in Electrohypersensitive Patients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 317
- 试验地点
- 1
- 主要终点
- Possible migraine attack
研究概览
简要总结
The investigators propose here by the use of the French version of the migraine disease screening questionnaire (ID Migraine ™) to study the prevalence of migraine disease in a population of electrohypersensitive patients
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Possible migraine attack
时间窗: 12 months
With the number of positive response to the French version of the migraine disease screening questionnaire, we are looking for the patients declaring themselves electrohypersensitive if they have had headaches in the last 12 months with characteristics that could evoke a migraine attack.
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Peripheral Electrical Stimulation for Migraine PreventionMigraineNCT03900611Taipei Veterans General Hospital, Taiwan120
招募中
不适用
HD-EEG Connectivity Changes in Migraine Patients Undergoing Treatment With Anti-CGRP mAbsMigraine DisordersChronic MigraineEpisodic MigraineNCT06155123IRCCS National Neurological Institute "C. Mondino" Foundation60
招募中
不适用
Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic MigraineChronic MigraineEpisodic MigraineMigraineNCT06603558AbbVie3,000
进行中（未招募）
不适用
Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With MigraineMigraineNCT06543914AbbVie1,314
Unknown
3 期
Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17)MigraineNCT05127954AbbVie1,200